Form 13-F position report

GILEAD SCIENCES INC

Reported by AQR CAPITAL MANAGEMENT LLC

GILD CUSIP 375558103 Manager CIK 0001167557

Reported 6,095,793 shares, up 3,383,767 (124.8%) from the prior quarter.

Reported value 132.9%; share count 124.8% vs. the prior quarter.

Added
% of reported 13F value 0.85% This manager · Q2 2022
Shares 6,095,793 Quarter-end amount reported
Reported value $375,562,000 Fair value at quarter end
Consecutive quarters held 37 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 79462000
2021-12-31 89302000
2022-03-31 161230000
2022-06-30 375562000
2022-09-30 340112000
2022-12-31 321783091
2023-03-31 287130588
2023-06-30 324668875
2023-09-30 357740149
2023-12-31 312669810
2024-03-31 242802062
2024-06-30 140861363
2024-09-30 162635120
2024-12-31 167517983
2025-03-31 207369860
2025-06-30 272212219
2025-09-30 264129514
2025-12-31 330777425
2026-03-31 162094086
2026-06-30 86936071

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for GILEAD SCIENCES INC held by AQR CAPITAL MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 695,432 -469,371 (-40.3%) 0.03% $86,936,071 2026-08-14
Q1 2026 Reduced 1,164,803 -1,530,141 (-56.8%) 0.07% $162,094,086 2026-05-15
Q4 2025 Added 2,694,944 +315,398 (13.3%) 0.17% $330,777,425 2026-02-17
Q3 2025 Reduced 2,379,546 -91,292 (-3.7%) 0.17% $264,129,514 2025-11-14
Q2 2025 Added 2,470,838 +606,168 (32.5%) 0.23% $272,212,219 2025-08-14
Q1 2025 Added 1,864,670 +51,116 (2.8%) 0.21% $207,369,860 2025-05-15
Q4 2024 Reduced 1,813,554 -129,518 (-6.7%) 0.22% $167,517,983 2025-02-14
Q3 2024 Reduced 1,943,072 -110,001 (-5.4%) 0.22% $162,635,120 2024-11-14
Q2 2024 Reduced 2,053,073 -1,261,631 (-38.1%) 0.22% $140,861,363 2024-08-14
Q1 2024 Reduced 3,314,704 -549,472 (-14.2%) 0.41% $242,802,062 2024-05-15
Q4 2023 Reduced 3,864,176 -909,512 (-19.1%) 0.59% $312,669,810 2024-02-14
Q3 2023 Added 4,773,688 +531,314 (12.5%) 0.74% $357,740,149 2023-11-14
Q2 2023 Added 4,242,374 +731,362 (20.8%) 0.69% $324,668,875 2023-08-14
Q1 2023 Reduced 3,511,012 -259,147 (-6.9%) 0.63% $287,130,588 2023-05-15
Q4 2022 Reduced 3,770,159 -1,743,093 (-31.6%) 0.73% $321,783,091 2023-02-14
Q3 2022 Reduced 5,513,252 -582,541 (-9.6%) 0.83% $340,112,000 2022-11-14
Q2 2022 Added 6,095,793 +3,383,767 (124.8%) 0.85% $375,562,000 2022-08-15
Q1 2022 Added 2,712,026 +1,482,141 (120.5%) 0.31% $161,230,000 2022-05-16
Q4 2021 Added 1,229,885 +92,279 (8.1%) 0.16% $89,302,000 2022-02-14
Q3 2021 Reduced 1,137,606 -18,824 (-1.6%) 0.15% $79,462,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1678 managers reported GILEAD SCIENCES INC for Q2 2022.

Managers reporting GILEAD SCIENCES INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 126,937,611 +5,228,246 0.25% $7,846,014,000 37 qtrs
VANGUARD GROUP INC Added 110,396,077 +4,787,719 0.19% $6,823,581,000 37 qtrs
STATE STREET CORPORATION Reduced 57,946,936 -24,023 0.21% $3,581,700,000 37 qtrs
Capital Research Global Investors Added 55,975,980 +24,601 1.08% $3,459,876,000 37 qtrs
Capital World Investors Added 52,859,468 +3,357,616 0.69% $3,267,332,000 37 qtrs
Dodge & Cox Reduced 36,966,627 -60,003 1.58% $2,284,907,000 32 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 23,172,575 +468,908 0.21% $1,429,762,000 37 qtrs
MORGAN STANLEY Added 17,826,626 +4,321,514 0.14% $1,101,863,000 37 qtrs
ARROWSTREET CAPITAL LIMITED PARTNERSHIP Reduced 15,668,185 -2,334,029 1.37% $968,451,000 22 qtrs
NORTHERN TRUST CORPORATION Added 15,313,169 +343,918 0.2% $946,506,000 37 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
4,231,618
Shared
0
None
1,864,175

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.